In HCC, Rae1 is expressed on the surface of HCC cells, and this factor, as a ligand of NKG2D, the NK cell activation receptor, can activate NK cells and promote their anti-tumor immunity. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.